Brain Cancer Awareness Month 2026: Precision Matters in Stereotactic Radiotherapy

May is Brain Cancer Awareness Month, a time to recognize the challenges faced by patients, clinicians, and researchers working to improve outcomes in one of the most demanding areas of oncology.

In brain tumor treatment, precision is essential. Sensitive anatomical structures and complex target geometries require radiotherapy systems capable of delivering highly accurate dose distributions with minimal deviation. Even the smallest positioning or beam-shaping error can have a significant clinical impact.

At gKteso, we support high-precision stereotactic radiosurgery (SRS) workflows through technologies designed specifically for cranial radiotherapy. Our ultrafine multileaf collimators (MLCs) enable highly accurate beam shaping for complex treatment plans, while the RPS Head provides stable and reproducible cranial positioning with precise angular correction capabilities.

Together, these technologies help clinicians improve targeting accuracy, workflow consistency, and treatment confidence in stereotactic applications.

Because better outcomes begin with better precision.

This month, we stand with the global community working to advance brain cancer research, treatment innovation, and patient care worldwide.